Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in
  • Log out

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
  • Log out
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

March 17, 2009; 72 (11) Editorials

Sensitivity vs specificity

Progress and pitfalls in defining MRI criteria for pediatric MS

Tanuja Chitnis, Istvan Pirko
First published March 16, 2009, DOI: https://doi.org/10.1212/01.wnl.0000344414.57976.97
Tanuja Chitnis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Istvan Pirko
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Sensitivity vs specificity
Progress and pitfalls in defining MRI criteria for pediatric MS
Tanuja Chitnis, Istvan Pirko
Neurology Mar 2009, 72 (11) 952-953; DOI: 10.1212/01.wnl.0000344414.57976.97

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
327

Share

  • Article
  • Info & Disclosures
Loading

Pediatric multiple sclerosis (MS) is clearly underrecognized and is often misdiagnosed as acute disseminated encephalomyelitis (ADEM), or as one of many relapsing pediatric neurologic conditions. Up to 5% of MS cases have a pediatric onset,1 and there are an estimated 10,000 cases in the United States alone.2 Recently, the International Pediatric MS Study Group proposed new clinical criteria for pediatric MS and related demyelinating disorders.3 However, definitive MRI criteria for these conditions are lacking. Recent studies have shown that at the time of their MS-defining attack, children meet McDonald MRI criteria only 67% of the time, suggesting a lower lesion burden at the time of presentation compared to adults.4 Previously published studies have suggested that the presence of periventricular and corpus callosum well-defined lesions may be sensitive predictors of MS after a first attack in childhood.5 Thus, neuroimaging biomarkers are powerful tools that may assist in both diagnosis and prognostication for demyelinating disorders in children.

In a pair of articles published in this issue of Neurology®, Callen and a well-recognized team of authors6,7 contrasted the MRI features of clinically definite MS in children with ADEM and with other neurologic diseases. In the first publication, they propose new criteria for differentiating MS from ADEM at first presentation.6 This is an important issue: while adult MS often starts with a distinct clinically isolated demyelinating syndrome (CIS), ADEM may be the first manifestation of pediatric MS in up to one fifth of cases.8 The authors studied 28 MS and 20 ADEM cases that had not converted to MS, defined using the International Pediatric MS Study Group consensus criteria.3 Although cases were followed for at least 2 years (mean 4.1 years), it is conceivable that some may still develop MS in the future. Multiphasic and recurrent ADEM cases were excluded and the study was not designed to clarify any potential confusion regarding MS and those entities. Only universally available MRI sequences were used, which makes the findings easily applicable at any medical center. However, spinal cord MRI, volumetric studies, and advanced MRI techniques addressing changes in normal-appearing gray and white matter may all have provided useful additional contribution to the differentiation of ADEM from MS.

In the second study, the authors compared MRI features of the first and second relapses in cases of clinically definite pediatric MS with cases of pediatric migraine and CNS lupus, and on this basis, propose revisions to the McDonald MRI criteria9 when applied to children.7 One of the motivations for these studies is the absence of definitive MRI criteria for childhood-onset MS, despite the development of consensus clinical criteria3; however, it is unclear how relevant the entities of migraine and CNS lupus are as comparison cohorts.

The two studies yielded some overlapping as well as divergent findings. Using a forward stepwise conditional logistic regression approach, the following qualitative MRI variables were found to be significant in distinguishing a first attack of pediatric MS from ADEM: 1) presence of T1 black holes; 2) presence of two or more periventricular lesions; 3) absence of diffuse bilateral lesions. Of note, diffuse bilateral lesions were the weakest of these predictors, were only seen below age 10, and mostly in ADEM. In contrast, MRI criteria that the authors propose as effective in distinguishing between pediatric MS at the time of the MS-defining relapse from migraine and CNS lupus were 1) presence of five or more lesions (as opposed to nine lesions in the McDonald criteria9); 2) two or more periventricular lesions (as opposed to three or more); 3) one brainstem lesion (as opposed to one infratentorial lesion). Juxtacortical lesions were not found to be significant, whereas contrast-enhancing lesions were not studied due to the low number of available scans. The reason for omitting postcontrast scans was likely related to the inconvenience of IV administration in children, but a perceived fear of triggering nephrogenic systemic fibrosis (NSF) or nephrogenic fibrosing dermopathy (NFD) may also have played a role. NSF and NFD have only been reported in patients with severe renal dysfunction, hepatorenal syndrome, or in the perioperative liver transplantation period.10 In general, it is not advised to administer gadolinium to children below the age of 1, but no other pediatric advisories exist. In the few patients with postgadolinium scans, one enhancing lesion could perhaps substitute for five T2 hyperintense lesions without any reduction of sensitivity, but this requires further validation.

The ADEM-MS MRI criteria were 81% sensitive and 95% specific in distinguishing ADEM from a first attack of MS. In contrast, the pediatric MS MRI criteria were only 75% sensitive and 25% specific when applied to the ADEM-first attack cohort. Thus, specificity may have to be sacrificed for sensitivity, depending on the question. The relative absence of black holes in ADEM compared to eventual MS cases suggests that ADEM may be a less destructive process; however, “black holes” in the MS literature usually refers to chronic, nonenhancing lesions, whereas in this article, most black holes were transient hypointensities in contrast-enhancing lesions. Longitudinal assessment for chronic black holes was not performed.

The studies by Callen et al. represent a positive step toward defining MRI criteria for pediatric MS, and in prognostication after an initial demyelinating event in childhood. However, larger prospective studies, which employ standardized protocols and include brain and spinal cord imaging, are required to validate their proposed MRI criteria for pediatric MS. Diagnostic and prognostic MRI criteria will have to balance the demands of sensitivity and specificity given the multiple mimics of pediatric MS, and the unclear immunopathogenetic relationship with ADEM. Given that children with MS are in close proximity to the potential inciting events of MS, definitive neuroimaging studies are not only essential for diagnosis and prognosis, but may hold the key to unlocking the earliest pathogenic events in MS.

Footnotes

  • Supported by the Pediatric Multiple Sclerosis Centers of Excellence Grant from the National Multiple Sclerosis Society, USA (T.C.).

    Disclosure: The authors report no disclosures.

    See pages 961 and 968

REFERENCES

  1. ↵
    Renoux C, Vukusic S, Confavreux C. The natural history of multiple sclerosis with childhood onset. Clin Neurol Neurosurg 2008;110:897–904.
    OpenUrlCrossRefPubMed
  2. ↵
    Belman AL, Chitnis T, Renoux C, Waubant E. Challenges in the classification of pediatric multiple sclerosis and future directions. Neurology 2007;68(16 suppl 2):S70–74.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Krupp LB, Banwell B, Tenembaum S. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 2007;68(16 suppl 2):S7–12.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Hahn CD, Shroff MM, Blaser SI, Banwell BL. MRI criteria for multiple sclerosis: evaluation in a pediatric cohort. Neurology 2004;62:806–808.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Mikaeloff Y, Adamsbaum C, Husson B, et al. MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood. Brain 2004;127:1942–1947.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Callen DJA, Shroff MM, Branson HM, et al. Role of MRI in the differentiation of ADEM from MS in children. Neurology 2009;72:968–973.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    Callen DJA, Shroff MM, Branson HM, et al. MRI in the diagnosis of pediatric multiple sclerosis. Neurology 2009;72:961–967.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Mikaeloff Y, Caridade G, Husson B, Suissa S, Tardieu M. Acute disseminated encephalomyelitis cohort study: prognostic factors for relapse. Eur J Paediatr Neurol 2007;11:90–95.
    OpenUrlPubMed
  9. ↵
    Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria.” Ann Neurol 2005;58:840–846.
    OpenUrlCrossRefPubMed
  10. ↵
    FDA Public Health Advisory re: nephrogenic systemic fibrosis or nephrogenic fibrosing dermopathy (NSF/NFD). Available at: http://www.ismrm.org/special/NSF.htm. Accessed February 3, 2009.
View Abstract

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Footnotes
    • REFERENCES
  • Info & Disclosures
Advertisement

Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study

Dr. Robert Shapiro and Dr. Amynah Pradhan

► Watch

Related Articles

  • MRI in the diagnosis of pediatric multiple sclerosis
  • Role of MRI in the differentiation of ADEM from MS in children

Topics Discussed

  • All Pediatric
  • Multiple sclerosis
  • MRI
  • Acute disseminated encephalomyelitis

Alert Me

  • Alert me when eletters are published
Neurology: 100 (5)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise